Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

THOMAS KEPCZYK

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1629062344
CMS profile
209833
Location
SAN MARCOS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$2,200.12

97 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,200.12 97

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

THOMAS KEPCZYK

NPI 1629062344 · CMS profile ID 209833

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

SAN MARCOS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1629062344?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
THOMAS KEPCZYK, NPI 1629062344, CMS profile ID 209833. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1629062344?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). THOMAS KEPCZYK, NPI 1629062344, CMS profile ID 209833. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1629062344?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
THOMAS KEPCZYK, NPI 1629062344, CMS profile ID 209833, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–97 of 97 matching records. This page contains 47 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1629062344?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

97 matching records · $2,200.12 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 97 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–97 of 97.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Phathom Pharmaceuticals, Inc. $4.1607/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219256601 CMS
ABBVIE INC. $22.1507/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181137 CMS
ABBVIE INC. $3.8707/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181135 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.4107/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232013075 CMS
ABBVIE INC. $9.9607/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181133 CMS
Phathom Pharmaceuticals, Inc. $13.2906/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219356442 CMS
Janssen Scientific Affairs, LLC $146.7406/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174200223 CMS
ABBVIE INC. $11.7406/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181131 CMS
ABBVIE INC. $22.3006/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181129 CMS
Janssen Biotech, Inc. $19.1806/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175156347 CMS
ABBVIE INC. $18.8605/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181127 CMS
Madrigal Pharmaceuticals $25.8105/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248276841 CMS
Ardelyx, Inc. $29.0405/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247858395 CMS
Janssen Biotech, Inc. $8.4105/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175156287 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $23.5305/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232013073 CMS
Lilly USA, LLC $16.5505/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186856995 CMS
Intercept Pharmaceuticals, Inc. $13.5205/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249878010 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.2005/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232013067 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.3505/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223868728 CMS
ABBVIE INC. $21.8905/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181125 CMS
Lilly USA, LLC $20.9105/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186904504 CMS
QOL Medical, LLC $28.9805/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1185007865 CMS
ABBVIE INC. $8.6004/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181123 CMS
Takeda Pharmaceuticals U.S.A., Inc. $33.3804/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223931498 CMS
Madrigal Pharmaceuticals $26.6904/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248276839 CMS
Intercept Pharmaceuticals, Inc. $15.8104/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249878008 CMS
ABBVIE INC. $27.3304/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181121 CMS
Janssen Biotech, Inc. $11.3603/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175155929 CMS
ABBVIE INC. $4.8203/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181119 CMS
QOL Medical, LLC $26.9303/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1185007825 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $10.5003/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232013069 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.7103/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223817458 CMS
Phathom Pharmaceuticals, Inc. $14.5103/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219356466 CMS
ABBVIE INC. $20.9803/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181117 CMS
Lilly USA, LLC $22.9002/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186896877 CMS
Intercept Pharmaceuticals, Inc. $14.8402/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249878006 CMS
PFIZER INC. $16.6902/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228872322 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.1902/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1232013071 CMS
ABBVIE INC. $121.7102/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181115 CMS
Lilly USA, LLC $20.1202/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186896875 CMS
ABBVIE INC. $21.1801/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181113 CMS
Intercept Pharmaceuticals, Inc. $14.2801/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249878004 CMS
ABBVIE INC. $16.7901/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181111 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.7201/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223854933 CMS
Intercept Pharmaceuticals, Inc. $13.6401/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1249878002 CMS
ABBVIE INC. $20.1301/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202181109 CMS
Phathom Pharmaceuticals, Inc. $17.4801/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1219356464 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,736.65 102
PY2020 $929.12 54
PY2021 $1,535.20 102
PY2022 $1,759.14 100
PY2023 $1,931.14 108
PY2024 $2,476.69 116
PY2025 $2,200.12 97

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $56,254.91 8
PY2024 Principal investigator $81,763.44 12
PY2023 Principal investigator $110,099.12 32
PY2022 Principal investigator $162,936.24 42
PY2021 Principal investigator $173,628.01 27
PY2020 Principal investigator $150,304.36 21
PY2019 Principal investigator $255,284.88 32

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Madrigal Pharmaceuticals $13,320.60 12/17/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
A 52WEEK PHASE 3 OPENLABEL EXTENSION STUDY WITH A DOUBLEBLIND LEADIN TO EVALUATE SAFETY AND BIOMARKERS OF RESMETIROM MGL3196 IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE NAFLD MAESTRONAFLDOPENLABELEXTENSION MAESTRONAFLDOLE No dispute reported 06/30/2026 1248254208
Principal investigator 1 Madrigal Pharmaceuticals $1,147.50 12/03/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
A 52WEEK PHASE 3 OPENLABEL EXTENSION STUDY WITH A DOUBLEBLIND LEADIN TO EVALUATE SAFETY AND BIOMARKERS OF RESMETIROM MGL3196 IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE NAFLD MAESTRONAFLDOPENLABELEXTENSION MAESTRONAFLDOLE No dispute reported 06/30/2026 1248253269
Principal investigator 1 Madrigal Pharmaceuticals $962.55 09/02/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
A 52WEEK PHASE 3 OPENLABEL EXTENSION STUDY WITH A DOUBLEBLIND LEADIN TO EVALUATE SAFETY AND BIOMARKERS OF RESMETIROM MGL3196 IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE NAFLD MAESTRONAFLDOPENLABELEXTENSION MAESTRONAFLDOLE No dispute reported 06/30/2026 1248249352
Principal investigator 1 Madrigal Pharmaceuticals $6,075.00 08/06/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
A PHASE 3 MULTINATIONAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY OF MGL3196 RESMETIROM IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS NASH AND FIBROSIS TO RESOLVE NASH AND REDUCE PROGRESSION TO CIRRHOSIS ANDOR HEPATIC DECOMPENSATION No dispute reported 06/30/2026 1248248048
Principal investigator 1 Madrigal Pharmaceuticals $15,818.08 07/10/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
A PHASE 3 MULTINATIONAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY OF MGL3196 RESMETIROM IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS NASH AND FIBROSIS TO RESOLVE NASH AND REDUCE PROGRESSION TO CIRRHOSIS ANDOR HEPATIC DECOMPENSATION No dispute reported 06/30/2026 1248246897
Principal investigator 1 Madrigal Pharmaceuticals $4,546.53 05/15/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
A PHASE 3 MULTINATIONAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY OF MGL3196 RESMETIROM IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS NASH AND FIBROSIS TO RESOLVE NASH AND REDUCE PROGRESSION TO CIRRHOSIS ANDOR HEPATIC DECOMPENSATION No dispute reported 06/30/2026 1248243748
Principal investigator 1 Madrigal Pharmaceuticals $14,255.05 03/03/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
A PHASE 3 MULTINATIONAL DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED STUDY OF MGL3196 RESMETIROM IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS NASH AND FIBROSIS TO RESOLVE NASH AND REDUCE PROGRESSION TO CIRRHOSIS ANDOR HEPATIC DECOMPENSATION No dispute reported 06/30/2026 1248240080
Principal investigator 1 Madrigal Pharmaceuticals $129.60 01/29/2025 Non-covered Recipient Entity
TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC
A 52WEEK PHASE 3 OPENLABEL EXTENSION STUDY WITH A DOUBLEBLIND LEADIN TO EVALUATE SAFETY AND BIOMARKERS OF RESMETIROM MGL3196 IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE NAFLD MAESTRONAFLDOPENLABELEXTENSION MAESTRONAFLDOLE No dispute reported 06/30/2026 1248238835

Ownership and Investment Interests

One row per program year and measure, newest year first · the amount invested and the value of the interest are never added together

Program yearMeasureAmountRecords
PY2024 Amount invested $0.00 1
PY2024 Value of interest $30,371.84 1
PY2023 Amount invested $0.00 1
PY2023 Value of interest $30,371.84 1
PY2022 Amount invested $345.82 1
PY2022 Value of interest $1,907.69 1
PY2021 Amount invested $1,247.84 1
PY2021 Value of interest $1,560.22 1

Ownership and Investment Interests are a separate CMS dataset, shown here separately and never added to payments.

Ownership and investment interests are reported as the value of an interest held, not as a payment received. They are a different measure from the payment total on this page and are never combined with it.

Ownership and Investment Interests records

Ordering applied by this site (program year, newest first, then company) · record values are shown as CMS published them

4 records · PY2021–2024

Ownership and Investment Interests records (CSV)

Program yearCompanyAmount invested Value of interestTerms of interestInterest held by Dispute statusPublishedRecord ID
PY2024 GastroGPO, LLC $0.00 $30,371.84 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 1124819243
PY2023 GastroGPO, LLC $0.00 $30,371.84 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 1050730115
PY2022 GastroGPO, LLC $345.82 $1,907.69 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 955000351
PY2021 GastroGPO, LLC $1,247.84 $1,560.22 Common Stock Physician Covered Recipient No dispute reported 06/30/2026 854914667